Compared with an individual patient data approach, the effect estimates provided for BRCA mutations in this meta-analysis cannot be fully adjusted for other potential influential factors, such as tumor stage, grade, nodal status, hormone receptors or systemic treatment. Here, NR4A1 is linked to neoplasm.